BOSTON--(BUSINESS WIRE)--Feb. 7, 2017--
Flex Pharma, Inc. (NASDAQ: FLKS) today announced that Company management
will present a corporate overview at the 2017 BIO CEO & Investor
Conference on Tuesday, February 14, 2017 at 10:00 a.m.
A live webcast of Flex Pharma’s presentations at these conferences may
be accessed in the Investor section of the Company’s website at www.flex-pharma.com.
Please log on to the Flex Pharma website approximately 15 minutes prior
to the scheduled webcast to ensure adequate time for any software
downloads that may be required. A replay of the webcast will be
available on Flex Pharma’s website for 2 weeks following each
About Flex Pharma
Flex Pharma, Inc. is a biotechnology company that is developing
innovative and proprietary treatments for cramps and spasms associated
with the severe neurological diseases of ALS, MS and peripheral
neuropathies such as Charcot-Marie-Tooth (CMT). Flex Pharma was founded
by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel
Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of
ion channels and neurobiology, along with Chair and CEO Christoph
Westphal, M.D., Ph.D.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170207006296/en/
Source: Flex Pharma, Inc.
Flex Pharma, Inc.
Elizabeth Woo, 617-874-1829
Relations & Corporate Communications